首页> Cold Spring Harbor molecular case studies> Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case report.

Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case report.

导出 LinkOut

翻译打印收藏纠错

第一作者： Christiane,Wiedemann

第一单位： Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital and National Center for Tumor Diseases, Heidelberg, 69126 Germany.

作者： Christiane,Wiedemann ^[1] ; Daniel,Kazdal ^[2] ; Jelena,Cvetkovic ^[1] ; Julia,Kunz ^[1] ; David,Fisch ^[1] ; Martina,Kirchner ^[3] ; Mark,Kriegsmann ^[2] ; Holger,Sültmann ^[4] ; Claus-Peter,Heussel ^[5] ; Helge,Bischoff ^[1] ; Michael,Thomas ^[6] ; Albrecht,Stenzinger ^[2] ; Petros,Christopoulos ^[6]

作者单位： Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital and National Center for Tumor Diseases, Heidelberg, 69126 Germany. ^[1] Institute of Pathology, Heidelberg University Hospital, Heidelberg, 69120 Germany.;Translational Lung Research Center Heidelberg (TLRC-H), member of the German Center for Lung Research (DZL), Heidelberg, 69120 Germany. ^[2] Institute of Pathology, Heidelberg University Hospital, Heidelberg, 69120 Germany. ^[3] Translational Lung Research Center Heidelberg (TLRC-H), member of the German Center for Lung Research (DZL), Heidelberg, 69120 Germany.;Division of Cancer Genome Research, German Cancer Research Center (DKFZ), Heidelberg, 69120 Germany. ^[4] Translational Lung Research Center Heidelberg (TLRC-H), member of the German Center for Lung Research (DZL), Heidelberg, 69120 Germany.;Department of Radiology with Nuclear Medicine, Thoraxklinik at Heidelberg University Hospital, Heidelberg, 69126 Germany. ^[5] Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital and National Center for Tumor Diseases, Heidelberg, 69126 Germany.;Translational Lung Research Center Heidelberg (TLRC-H), member of the German Center for Lung Research (DZL), Heidelberg, 69120 Germany. ^[6]

关键词 lung adenocarcinoma

医学主题词女(雌)性(Female);人类(Humans);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);受体蛋白质酪氨酸激酶类(Receptor Protein-Tyrosine Kinases);乳腺肿瘤(Breast Neoplasms);抗药性, 肿瘤(Drug Resistance, Neoplasm);乳房切除术(Mastectomy);肺肿瘤(Lung Neoplasms);内酰胺类, 大环(Lactams, Macrocyclic);突变(Mutation);癌(Carcinoma);肺(Lung)

DOI 10.1101/mcs.a006234

PMID 36207130

发布时间 2023-01-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cold Spring Harbor molecular case studies

2022年8卷6期

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Cold Spring Harbor molecular case studies

2022年8卷6期

检索历史清除

Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case report.

Cold Spring Harbor molecular case studies

相似文献

同项目论文

Cold Spring Harbor molecular case studies

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case report.

Cold Spring Harbor molecular case studies

相似文献

同项目论文

Cold Spring Harbor molecular case studies

相关期刊

检索历史清除